All Stories

  1. Incidence of hepatitis C virus antibody seroconversion among people who inject drugs in Tbilisi, Georgia, 2017–2019

    Article • International Journal of Drug Policy, March 2026, Elsevier

    Dr Nikoloz Chkhartishvili

  2. Analysis of tuberculosis preventive treatment cascade among people living with HIV in Georgia: a mixed methods study

    Article • Open Forum Infectious Diseases, December 2025, Oxford University Press (OUP)

    Dr Nikoloz Chkhartishvili

  3. Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized patients with COVID-19: real-world data from a resource-limited country

    Article • International Journal of Infectious Diseases, April 2023, Elsevier

    Dr Nikoloz Chkhartishvili

  4. HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe

    Article • HIV Medicine, December 2021, Wiley

    Dr Nikoloz Chkhartishvili

  5. Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps

    Article • HIV Medicine, September 2021, Wiley

    Dr Nikoloz Chkhartishvili

  6. Causes and outcomes of hospitalizations among people living with HIV in Georgia’s referral institution, 2012–2017

    Article • International Journal of STD & AIDS, February 2021, SAGE Publications

    Dr Nikoloz Chkhartishvili

  7. SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia

    Article • September 2020, Cold Spring Harbor Laboratory Press

    Dr Nikoloz Chkhartishvili

  8. Smoking and cessation-related attitudes among men who have sex with men in the country of Georgia

    Article • AIDS Care, August 2020, Taylor & Francis

    Dr Nikoloz Chkhartishvili

  9. HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe?

    Article • International Journal of Infectious Diseases, July 2020, Elsevier

    Dr Nikoloz Chkhartishvili

  10. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

    Article • AIDS, May 2020, Wolters Kluwer Health

    Dr Nikoloz Chkhartishvili

  11. Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2020, Wolters Kluwer Health

    Dr Nikoloz Chkhartishvili

  12. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia

    Article • BMC Infectious Diseases, January 2020, Springer Science + Business Media

    Dr Nikoloz Chkhartishvili

  13. The EuroSIDA study: 25 years of scientific achievements

    Article • HIV Medicine, October 2019, Wiley

    Dr Nikoloz Chkhartishvili

  14. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018

    Article • Clinical Infectious Diseases, September 2019, Oxford University Press (OUP)

    Dr Nikoloz Chkhartishvili

  15. Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia

    Article • International Journal of STD & AIDS, September 2019, SAGE Publications

    Dr Nikoloz Chkhartishvili

  16. Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia

    Article • Journal of Medical Virology, October 2018, Wiley

    Dr Nikoloz Chkhartishvili

  17. Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations

    Article • AIDS, October 2018, Wolters Kluwer Health

    Dr Nikoloz Chkhartishvili

  18. The Attitudes, Needs, and Requirements at End of Life in the Republic of Georgia (Comparative Analysis of Groups of Patients With Cancer and Elders)

    Article • Journal of Palliative Care, June 2018, SAGE Publications

    Professor Dimitri Kordzaia, Dr Nikoloz Chkhartishvili

  19. Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

    Article • AIDS, June 2018, Wolters Kluwer Health

    Dr Nikoloz Chkhartishvili

  20. Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

    Article • Eurosurveillance, May 2018, European Centre for Disease Control and Prevention (ECDC)

    Dr Nikoloz Chkhartishvili

  21. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era

    Article • Journal of the International AIDS Society, April 2018, Wiley

    Dr Nikoloz Chkhartishvili, Frederick Altice

  22. HIV Care in Central and Eastern Europe:How close are we to the target?

    Article • International Journal of Infectious Diseases, March 2018, Elsevier

    Dr Nikoloz Chkhartishvili

  23. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia

    Article • European Journal of Gastroenterology & Hepatology, November 2017, Wolters Kluwer Health

    Dr Nikoloz Chkhartishvili

  24. Late presentation of HIV infection in the country of Georgia: 2012-2015

    Article • PLOS One, October 2017, PLOS

    Dr Nikoloz Chkhartishvili

  25. Progress Toward Achieving the UNAIDS 90-90-90 Goals in HIV Care From Diagnosis to Durable Viral Suppression in the Country of Georgia

    Article • AIDS Research and Human Retroviruses, October 2017, Mary Ann Liebert Inc

    Dr Nikoloz Chkhartishvili

  26. Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care

    Article • SAGE Open Medicine, September 2017, SAGE Publications

    Dr Nikoloz Chkhartishvili, ekaterine ruadze

  27. Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

    Article • Hepatology Research, April 2017, Wiley

    Dr Nikoloz Chkhartishvili

  28. National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016

    Article • MMWR Morbidity and Mortality Weekly Report, October 2016, Centers for Disease Control MMWR Office

    Dr Nikoloz Chkhartishvili

  29. Significant Improvements Are Needed in HIV Care Continuum to Meet 90-90-90 Targets in Georgia

    Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), September 2016, SAGE Publications

    Dr Nikoloz Chkhartishvili

  30. Assessment of quality of life in people living with HIV in Georgia

    Article • International Journal of STD & AIDS, July 2016, SAGE Publications

    Dr Nikoloz Chkhartishvili

  31. Mismatch between physicians and family members views on communications about patients with chronic incurable diseases receiving care in critical and intensive care settings in Georgia: a quantitative observational survey

    Article • BMC Palliative Care, July 2016, Springer Science + Business Media

    Dr Nikoloz Chkhartishvili

  32. The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia

    Article • Virology Journal, February 2016, Springer Science + Business Media

    Dr Nikoloz Chkhartishvili

  33. High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment

    Article • Hepatology Research, March 2015, Wiley

    Dr Nikoloz Chkhartishvili

  34. The cascade of care in the Eastern European country of Georgia

    Article • HIV Medicine, June 2014, Wiley

    Dr Nikoloz Chkhartishvili

  35. Mortality and Causes of Death Among HIV-Infected Individuals in the Country of Georgia: 1989–2012

    Article • AIDS Research and Human Retroviruses, June 2014, Mary Ann Liebert Inc

    Dr Nikoloz Chkhartishvili

  36. Estimating HIV incidence in eastern European country of Georgia: 2010–2012

    Article • International Journal of STD & AIDS, March 2014, SAGE Publications

    Dr Nikoloz Chkhartishvili

  37. Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia

    Article • Journal of the International AIDS Society, January 2014, Wiley

    Dr Nikoloz Chkhartishvili

  38. Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia

    Article • AIDS Research and Therapy, January 2014, Springer Science + Business Media

    Dr Nikoloz Chkhartishvili

  39. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia

    Article • BMC Infectious Diseases, November 2013, Springer Science + Business Media

    Dr Nikoloz Chkhartishvili

  40. IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1

    Article • European Journal of Gastroenterology & Hepatology, July 2012, Wolters Kluwer Health

    Dr Nikoloz Chkhartishvili

  41. Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia

    Article • Journal of Medical Virology, May 2012, Wiley

    Dr Nikoloz Chkhartishvili

  42. Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia

    Article • AIDS Research and Treatment, January 2011, Hindawi Publishing Corporation

    Dr Nikoloz Chkhartishvili

  43. Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia

    Article • AIDS Research and Therapy, January 2011, Springer Science + Business Media

    Dr Nikoloz Chkhartishvili